Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal areaI

Lindgren, Gun; Lindblom, Bertil; Bratel, Annika Ternesten; Mölne, Lena; Larkö, Olle

doi:10.1034/j.1600-0420.2000.078004425.x

Cited by 19 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other authors have also observed the high prevalence of nodular BCC on the eyelids, which has been predominant type in this location. 10,11 In contrast, the superficial type of BCC appeared to be more typical for trunk and extremities, developing seldom on face; there were no superficial BCCs located on the eyelids in our patients. These differences in distribution of various types of BCC have been already observed.…”

Section: Discussioncontrasting

confidence: 64%

Basal Cell Carcinoma on the Eyelids: Own Experience

Salomon¹,

Bieniek²,

Baran³

et al. 2004

Dermatol Surg

View full text Add to dashboard Cite

Approximately 16% of all tumors were located on the eyelids. The majority of tumors were situated on the lower eyelid. Noduloulcerative clinical type was observed in 96.3% of tumors. This type was significantly more frequently found on eyelids than on trunk and extremities (p<0.00001). The histologic nodular type was the most common found on eyelids. It was significantly more common on eyelids than on trunk and extremities (p=0.002). The superficial type was significantly less frequently found on the eyelids (p<0.00001). The infiltrative type was significantly more seldom observed on the eyelids compared with other locations of head and neck region (p=0.048). Some technical aspects of reconstructive surgery of the eyelids are presented.

show abstract

Section: Discussioncontrasting

confidence: 64%

Basal Cell Carcinoma on the Eyelids: Own Experience

Salomon¹,

Bieniek²,

Baran³

et al. 2004

Dermatol Surg

View full text Add to dashboard Cite

show abstract

“…Other evidence for MMS efficacy comes largely from observational studies (Table 1 provides a summary of recurrence data). Only a few were multicentre [9][10][11][12][13][14][15] (many of which sampled the same Australian MMS database) with a follow-up of > 5 years, 9,[11][12][13][14][16][17][18][19][20][21][22] but there was significant loss to follow-up over time. Recurrence rates varied considerably.…”

Section: Recurrence/complete Excisionmentioning

confidence: 99%

A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma

Brown

Brindley

Hunt

et al. 2022

Clinical and Experimental Dermatology

View full text Add to dashboard Cite

Mohs micrographic surgery (MMS) is considered the gold-standard treatment for basal cell carcinoma (BCC) particularly for sites with a high risk of incomplete excision such as the central face, for tumours with an aggressive growth pattern and consequent unpredictable subclinical extension and for recurrent tumours. However, the process is more time-consuming than for standard excision (SE), and the magnitude of benefit is uncertain. This article aims to provide a more complete picture of current evidence, including a review of cosmetic outcomes, tissue-sparing ability and cost-effectiveness of MMS. Although robust evidence is lacking, there is a large volume of observational data supporting a low recurrence rate after MMS. The risk of incomplete excision and higher recurrence rate of SE favours the use of MMS at high-risk sites. There is some low-certainty evidence that MMS results in a smaller defect size compared with SE, and that incomplete excision with SE results in larger defects. Larger defects may affect cosmetic outcome but there is no direct evidence that MMS improves cosmetic outcome compared with SE. There is conflicting evidence regarding the cost of MMS compared with SE, as some studies consider MMS less expensive than SE and others consider it more expensive, which may reflect the healthcare setting. A multicentre 10-year randomized controlled trial comparing MMS and SE in the treatment of high-risk BCC would be desirable, but is unlikely to be feasible or ethical. Collection of robust registry data capturing both MMS and SE outcomes would provide additional long-term outcomes.

show abstract

“…Hence, our material has a different case mix from many other publications on the results of surgery according to Mohs. Our group has previously presented a study using a smaller base of material with shorter follow-up times ( 19 , 20 ).…”

mentioning

confidence: 99%

Results of Mohs’ Micrographic Surgery of Periocular Basal Cell Carcinoma: The Swedish Experience

Erripi,

Paussen,

Svedberg

2024

Acta Derm Venereol

View full text Add to dashboard Cite

The Department of Ophthalmology, Sahlgrenska University Hospital, has until recently been the only eye clinic in the Nordic countries to perform Mohs’ micrographic surgery of basal cell carcinoma. This has led to the practice of only the most complicated basal cell carcinomas being operated on with this technique. The purpose of this study was to present the results of these surgeries in patients with at least 5 years of follow-up. A retrospective study of all patients operated upon in 2010–2015 was performed. Data were gathered from their medical charts. Primary outcome was recurrence of basal cell carcinoma. One-hundred and sixty-seven patients were operated on. Mohs’ micrographic surgery was used for tumours that were judged as highly aggressive on preoperative biopsy, had ill-defined borders, had recurred after previous surgery, or a combination of these factors. Nine recurrences (5.4% of all radical Mohs’ micrographic surgeries) were diagnosed after a mean postoperative time of 37 months (4–84 months). Interestingly, all of these 9 recurrences after Mohs’ micrographic surgery were in patients who had such surgery because of a recurrent basal cell carcinoma to start with. Good results can be achieved when operating on the most complicated periocular basal cell carcinomas with Mohs’ micrographic surgery but special care has to be taken to ensure radical borders when operating on recurring basal cell carcinomas.

show abstract

Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal areaI

Abstract: ABSTRACT.Purpose: To analyse the characteristics of eyelid basal cell carcinomas excised using Mohs' micrographic technique.

Cited by 19 publications

References 15 publications

Basal Cell Carcinoma on the Eyelids: Own Experience

Basal Cell Carcinoma on the Eyelids: Own Experience

A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma

Results of Mohs’ Micrographic Surgery of Periocular Basal Cell Carcinoma: The Swedish Experience

Contact Info

Product

Resources

About